Detailed answers about NEUROFEEDBACK CENTRE AND RESEARCH LIMITED, including incorporation, status, business activity, and accounts information.
When was NEUROFEEDBACK CENTRE AND RESEARCH LIMITED founded?
NEUROFEEDBACK CENTRE AND RESEARCH LIMITED was officially incorporated on 29 June 2018 and is registered under company number 11440641. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is NEUROFEEDBACK CENTRE AND RESEARCH LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of NEUROFEEDBACK CENTRE AND RESEARCH LIMITED?
NEUROFEEDBACK CENTRE AND RESEARCH LIMITED's current status is Active - Proposal to Strike off. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does NEUROFEEDBACK CENTRE AND RESEARCH LIMITED do?
NEUROFEEDBACK CENTRE AND RESEARCH LIMITED operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is NEUROFEEDBACK CENTRE AND RESEARCH LIMITED's registered address?
The registered office address of NEUROFEEDBACK CENTRE AND RESEARCH LIMITED is S YODAIKEN FAIRWAYS HOUSE GEORGE STREET, PRESTWICH, MANCHESTER, UNITED KINGDOM, M25 9WS. This is the official address filed with Companies House for legal and statutory correspondence.
Is NEUROFEEDBACK CENTRE AND RESEARCH LIMITED financially stable?
The most recent accounts for NEUROFEEDBACK CENTRE AND RESEARCH LIMITED were made up to 30 June 2023, filed as MICRO ENTITY. Next accounts are due by 31 March 2025.